Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT01538264

Blood Flow MRI for Monitoring Brain Tumors

Blood Flow MRI for Monitoring of Glioma Angiogenesis

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
125 (estimated)
Sponsor
Beth Israel Deaconess Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The investigators are studying the use of an advanced magnetic resonance imaging (MRI) technique for measuring blood flow into brain tumors. This technique does not use radioactive tracers, and it can provide high quality images that can be obtained in a standard MRI scanner.

Detailed description

Our goals are: 1. To compare the blood flow measured with this technique with measures of tumor blood vessel density in pieces of the tumor surgically removed as a normal part of clinical treatment. This will confirm a relationship between the imaging measurements and the microscopic characteristics of tumors. 2. To compare the blood flow in tumors before therapy with the concentration of choline, an indicator of cell proliferation. This choline concentration can be measured with another MRI technique. This information will demonstrate the relationship between cell proliferation and blood supply and will also determine whether the choline measurement adds additional information that is clinically necessary. 3. To determine the reproducibility of blood flow measurements in tumors. This is necessary to better understand the sensitivity of the technique to changes in flow caused by a treatment or changes in tumor vascularity. 4. To monitor changes in blood flow after initial treatment. Since sometimes tumors can reappear, the repeated measures will help determine how useful this new imaging technique is at detecting such recurring tumors.

Conditions

Timeline

Start date
2006-06-01
Primary completion
2025-12-31
Completion
2025-12-31
First posted
2012-02-24
Last updated
2024-04-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01538264. Inclusion in this directory is not an endorsement.